The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy

Contraception

Volumn 72, Issue 1, 2005, Pages 33-39

  Aronsson, Annette ^a   Ulfgren, Ann Kristin ^a   Ståbi, Berit ^a   Stavreus Evers, Anneli ^a   Gemzell Danielsson, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cervical ripening; Matrix metalloproteinases; Misoprostol; MMP; TIMP

Indexed keywords

CD45 ANTIGEN; CD68 ANTIGEN; GELATINASE B; MISOPROSTOL; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; BIOPSY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDUCED ABORTION; INFLAMMATION; INFLAMMATORY CELL; NORMAL HUMAN; PREGNANCY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING; VACUUM ASPIRATION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CERVICAL RIPENING; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MISOPROSTOL; PREGNANCY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VACUUM CURETTAGE;

EID: 20444431601     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.02.012     Document Type: Article

References (30)

1. 2α methyl ester for preoperative cervical dilatation Contraception 23 1981 251 257
2. 1-methyl ester (Cervagem®) prior to vacuum aspiration Contraception 29 1984 457 464
3. S.W. Ngai, O.S. Tang, T. Lao, and P.C. Ho Oral misoprostol versus placebo for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation Contraception 51 1995 335 337
4. S.W. Ngai, Y.M. Chan, O.S. Tang, and P.C. Ho The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomized trial Hum Reprod 14 1999 2139 2142
5. A. Lawrie, G. Penny, and A.A. Templeton A randomized comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy Br J Obstet Gynaecol 103 1996 1117 1119
6. K. Gemzell Danielsson, L. Marions, A. Rodriguez, B.W. Spur, P.Y.K. Wong, and M. Bygdeman Comparison between oral and vaginal administration of misoprostol on uterine contractility Obstet Gynecol 93 1999 275 280
7. M. Zieman, S.K. Fong, N.L. Benowitz, D. Banskter, and P.D. Darney Absorption kinetics of misoprostol with oral and vaginal administration Obstet Gynecol 90 1997 88 92
8. O.S. Tang, H. Schweer, H.W. Seyberth, S.H.W. Lee, and P.C. Ho Pharmacokinetics of different routes of administration of misoprostol Hum Reprod 17 2002 332 336
9. F.C. Denison, S.C. Riley, C.L. Elliott, R.W. Kelly, A.A. Calder, and H.O. Critchley The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix Mol Hum Reprod 6 2000 541 548
10. G.C. Liggins Cervical ripening as an inflammatory reaction D.A. Ellwood A.B.M. Anderson The cervix in pregnancy and labour, clinical and biochemical investigations 1981 Churchill Livingstone Edinburgh (UK) 1 9
11. H. Bokström, M. Brännström, M. Alexandersson, and A. Norström Leukocyte subpopulations in the human uterine cervical stroma at early and term pregnancy Hum Reprod 12 1997 586 590
12. R.W. Kelly Inflammatory mediators and cervical ripening J Reprod Immunol 57 2002 217 224
13. D.F. Busiek, V. Baragi, L.C. Nehring, W.C. Parks, and H.G. Welgus Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones J Immunol 154 1995 6484 6491
14. U.T. Shankavaram, D.L. DeWitt, and L.M. Wahl Lipopolysaccharide induction of monocyte matrix metalloproteinases is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2 J Leukoc Biol 64 1998 221 227
15. W. Rath, R. Osmers, H.W. Stuhlsatz, and B.C. Adelmanngrill Biochemical fundamentals of cervical ripening and dilatation Z Geburtshilfe Perinatol 198 1994 186 195
16. M. Rampart, J. Van Damme, L. Zonnekyn, and A.G. Herman Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin Am J Pathol 135 1989 21 25
17. P.C. Leppert Anatomy and physiology of cervical ripening Clin Obstet Gynecol 2 1995 267 279
18. R.G.W. Osmers, B.C. Adelmann-Grill, W. Rath, H.W. Stuhlsatz, H. Tschesche, and W. Kuhn Biochemical events in cervical ripening dilatation during pregnancy and parturition J Obstet Gynaecol 21 1995 185 194
19. K. Blanchard, S. Clark, B. Winikoff, G. Gaines, G. Kabani, and C. Shannon Misoprostol for women's health. A review Obstet Gynecol 2 2002 316 332
20. M.K.B. Sennström, A. Brauner, Y. Lu, L.M.M. Granström, A.L. Malmström, and G.E. Ekman Interleukin-8 is a mediator of the final cervical ripening in humans Eur J Obstet Gynecol Reprod Biol 74 1997 89 92
21. L.C. Junqueira, M. Zugaib, G.S. Montes, O.M. Toledo, R.M. Krisztan, and K.M. Shigihara Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation Am J Obstet Gynecol 138 1980 273 281
22. K. Chwalisz, M. Benson, P. Scholz, J. Daum, H.M. Beier, and C. Hegele-Hartung Cervical ripening with the cytokines interleukin-8, interleukin-1 and tumour necrosis factor in guinea-pigs Hum Reprod 9 1994 2173 2181
23. T. Minamato, K. Arai, S. Hirakawa, and Y. Nagai Immunohistochemical studies on collagen types in the uterine cervix in pregnant and non-pregnant states Am J Obstet Gynecol 156 1987 138 144
24. D.L. Hulboy, L.A. Rudolph, and L.M. Matrisian Matrix metalloproteinases as mediators of reproductive function Mol Hum Reprod 3 1997 27 45
25. M.A. Ledingham, F.C. Denison, S.C. Riley, and J.E. Norman Matrix metalloproteinases -2 and -9 and their inhibitors (TIMPs) are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors Hum Reprod 14 1999 2089 2096
26. D. Stygar, H. Wang, Y.S. Vladic, G. Ekman, H. Eriksson, and L. Sahlin Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix Biol Reprod 67 2002 889 894
27. S.M. Wilhelm, I.E. Collier, B.L. Marmer, A.Z. Eisen, G.A. Grant, and G.I. Goldberg SV 40-transformed human lung fibroblasts secrete a 92-kDA type IV collagenase which is identical to that secreted by normal human macrophages J Biol Chem 264 1989 17213 17221
28. K. Imada, A. Ito, T. Sato, M. Namiki, H. Nagase, and Y. Mori Hormonal regulation of matrix metalloproteinase-9 gelatinase B gene expression in rabbit uterine cervical fibroblasts Biol Reprod 56 1997 575 580
29. A. Rådestad, and M. Bygdeman Cervical softening with mifepristone (RU 486) after pretreatment with naproxen A double-bind randomized study. Contraception 45 1992 221 227
30. L. Cheng, R.W. Kelly, K.J. Thong, R. Hume, and D.T. Baird The effect of mifepristone (RU486) on the immunohistochemical distribution of prostaglandin E and its metabolite in decidual and chorionic tissue in early pregnancy J Clin Endocrinol Metab 77 1993 873 877